RXRα has been implicated in the progression of various cancers. Alterations in RXRα expression or function can lead to uncontrolled cell proliferation and tumorigenesis. In some cancers, RXRα acts as a tumor suppressor, while in others, it may contribute to cancer progression. Targeting RXRα with specific agonists or antagonists is being explored as a therapeutic approach in oncology.
